Evidence map›Paper›PMID 26131103›Full record

ArticleInternational journal of clinical and experimental medicine2015

Alkannin inhibits growth and invasion of glioma cells C6 through IQGAP/mTOR signal pathway.

Chunyan Gao, Cunyin Liang, Zhengui Nie, Ying Liu, Junya Wang, Dongmei Zhang

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Alkannin Inhibits the Development of Ovarian Cancer by Affecting miR-4461.Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chunyan GaoYanjing Medical School, Capital University of Medical Sciences Beijing 101300, China.
Cunyin LiangYanjing Medical School, Capital University of Medical Sciences Beijing 101300, China.
Zhengui NieYanjing Medical School, Capital University of Medical Sciences Beijing 101300, China.
Ying LiuYanjing Medical School, Capital University of Medical Sciences Beijing 101300, China.
Junya WangYanjing Medical School, Capital University of Medical Sciences Beijing 101300, China.
Dongmei ZhangYanjing Medical School, Capital University of Medical Sciences Beijing 101300, China.
Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aims to explore the effect of alkannin on the growth and invasion of glioma cells and its mechanism.

methodsThe effects of alkannin on the growth and invasion of glioma cells were detected with MTT assay, clone forming test and transwell assay. The effects of alkannin on the cell cycle were detected with flow cytometry assay. The changes of cyclin, MMPs and IQGAP/mTOR signal pathway related proteins were detected with western blotting methods.

resultsAlkannin (1 μM, 3 μM and 10 μM) can significantly inhibit the growth, proliferation, migration and invasion of glioma cells C6 with dose dependent. Alkannin can block cell cycle in G1 phase with the increased concentration, which was related with the down-regulation of cyclinA1, cyclinA2 and cyclinD1 expression. Alkannin can also down-regulate the expression of MMP 2, MMP 9 and IQGAP. Alkannin has no effect on mTOR but can inhibit the phosphorylation of mTOR.

conclusionsAlkannin can inhibit the growth and invasion of glioma cells C6 through IQGAP/mTOR signal pathway.

Indexed as

Alkanninflow cytometry assayglioma cellsinvasionMMPsMTT assay

Identifiers

PMID26131103
PMCPMC4483937
OpenAlexW829244115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.